
Sage
Sage is a seed to Series D stage investment firm. It has made 11 investments. Their most common stage is series-a (42% of deals). Average disclosed round size is $57.3M (across 11 rounds with reported amounts).
Portfolio
11
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series C | $255M | Jun 2021 | |
| 和和誉生物 | Series D | $123M | Jan 2021 |
| AAbbisko Therapeutics | Series D | $123M | Jan 2021 |
| Series A | $2M | Jan 2021 | |
| Series A | $5M | Feb 2015 | |
| AArbor Surgical Technologies | Series B | $20M | Aug 2005 |
| Series A | — | — | |
| Series B | $61M | — | |
| Seed | $4.2M | — | |
| Seed | $5M | — | |
| Series A | $15M | — | |
| Series A | $17M | — |
Top Co-Investors
LAV3 shared
OrbiMed3 shared
Lake Bleu Capital3 shared
Warburg Pincus LLC3 shared
Hankang Capital2 shared
The Carlyle Group2 shared
GISEV Family Office2 shared
Nevcaut Ventures2 shared
Baird1 shared
Delphi Ventures1 shared
Alloy Labs1 shared
Affinity Partners1 shared
INDIE1 shared
Laurion Capital Management1 shared
Decheng Capital1 shared
Baidu Ventures1 shared
Sinovation Ventures1 shared
CPE1 shared
Last updated: 7 October 2026